GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Modern Dental Group 3600.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

7.14

-2.46%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in HKD, from our data supplier.

FY2025

Revenue

HK$3.74bn

FY2016FY2025

Net income

HK$597.0m

FY2016FY2025

Free cash flow

HK$691.1m

FY2016FY2025

Shareholders' equity

HK$3.29bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueHK$3.74bnHK$3.36bnHK$3.17bnHK$2.83bnHK$2.96bnHK$2.19bnHK$2.40bnHK$2.32bnHK$2.18bnHK$1.64bn
Gross profitHK$2.08bnHK$1.80bnHK$1.70bnHK$1.38bnHK$1.55bnHK$1.09bnHK$1.15bnHK$1.08bnHK$1.06bnHK$880.7m
Research and developmentHK$39.0mHK$43.6mHK$43.2mHK$40.1mHK$36.5mHK$6.4mHK$7.4mHK$13.8m——
Operating incomeHK$753.6mHK$537.0mHK$539.4mHK$306.1mHK$493.9mHK$282.8mHK$242.8mHK$173.3mHK$211.2mHK$225.0m
Net incomeHK$597.0mHK$408.0mHK$404.1mHK$220.5mHK$360.8mHK$107.8mHK$161.6mHK$85.4mHK$155.4mHK$101.5m
Diluted earnings per share0.640.440.430.230.380.110.170.090.160.10

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsHK$4.54bnHK$4.07bnHK$3.95bnHK$3.54bnHK$3.66bnHK$3.67bnHK$3.36bnHK$3.11bnHK$3.14bnHK$2.74bn
Cash and short-term investmentsHK$767.2mHK$816.8mHK$697.7mHK$447.7mHK$638.0mHK$697.8mHK$399.2mHK$420.6mHK$410.8mHK$357.4m
Total liabilitiesHK$1.24bnHK$1.35bnHK$1.31bnHK$1.21bnHK$1.30bnHK$1.41bnHK$1.34bnHK$1.11bnHK$1.04bnHK$922.3m
DebtHK$525.6mHK$924.2mHK$852.2mHK$788.2mHK$833.1mHK$1.03bnHK$1.00bnHK$809.2mHK$717.5mHK$621.2m
Shareholders' equityHK$3.29bnHK$2.72bnHK$2.63bnHK$2.32bnHK$2.35bnHK$2.25bnHK$2.02bnHK$2.00bnHK$2.10bnHK$1.82bn
Shares outstanding935m937m948m956m956m960m974m995m1,001m992m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsHK$763.1mHK$521.2mHK$575.8mHK$258.3mHK$525.1mHK$376.3mHK$313.6mHK$204.9mHK$194.7mHK$181.7m
Capital spending−HK$72.0m−HK$141.8m−HK$159.7m−HK$185.4m−HK$141.5m−HK$72.4m−HK$147.5m−HK$141.7m−HK$193.7m−HK$86.9m
Free cash flowHK$691.1mHK$379.4mHK$416.0mHK$72.9mHK$383.7mHK$303.9mHK$166.1mHK$63.2mHK$966,000HK$94.8m
Dividends paid−HK$186.3m−HK$160.7m−HK$99.0m−HK$77.5m−HK$186.5m−HK$21.2m−HK$44.1m−HK$40.0m−HK$34.0m−HK$21.0m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueHK$2.03bnHK$1.90bnHK$1.83bnHK$1.66bnHK$1.70bnHK$1.57bnHK$1.60bnHK$1.40bn
Gross profitHK$1.18bnHK$1.08bnHK$1.01bnHK$884.9mHK$914.0mHK$833.4mHK$867.3mHK$688.0m
Operating incomeHK$474.7mHK$378.6mHK$345.5mHK$258.1mHK$304.3mHK$248.8mHK$289.9mHK$163.9m
Net incomeHK$374.3mHK$311.7mHK$285.2mHK$192.8mHK$215.2mHK$192.9mHK$211.2mHK$120.6m
Diluted earnings per share0.400.330.310.210.230.200.220.13
Cash from operations—HK$464.0mHK$289.0mHK$289.0mHK$189.0mHK$361.0mHK$197.0mHK$187.0m
Capital spending—−HK$35.0m−HK$36.0m−HK$55.0m−HK$98.0m−HK$102.0m−HK$57.0m−HK$84.0m
Free cash flow—HK$429.0mHK$253.0mHK$234.0mHK$91.0mHK$259.0mHK$140.0mHK$103.0m
Total assetsHK$4.80bnHK$4.54bnHK$4.40bnHK$4.07bnHK$4.03bnHK$3.95bnHK$3.70bnHK$3.54bn
Cash and short-term investmentsHK$829.2mHK$767.2mHK$595.3mHK$816.8mHK$726.8mHK$697.9mHK$525.7mHK$447.7m
DebtHK$122.4mHK$525.6mHK$768.6mHK$924.2mHK$859.0mHK$852.2mHK$812.8mHK$788.2m
Shareholders' equityHK$3.53bnHK$3.29bnHK$2.99bnHK$2.72bnHK$2.70bnHK$2.63bnHK$2.47bnHK$2.32bn

Financial ratios

Data as of 14 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin55.8%53.5%53.6%48.9%52.5%49.8%
Operating margin20.2%17.2%17.4%11.2%16.5%7.3%
Net margin16.0%12.1%12.7%7.8%12.2%4.9%
Return on equity18.2%15.0%15.4%9.5%15.4%4.8%
Return on assets13.1%10.0%10.2%6.2%9.9%2.9%
Free cash flow yield11.5%9.1%10.0%6.0%9.0%6.0%
Revenue growth11.1%6.1%12.1%-4.2%34.9%-8.7%
Earnings growth46.3%1.0%83.3%-38.9%234.8%-33.3%
Current ratio3.24x3.02x2.83x2.39x2.09x2.31x
Debt to equity0.16x0.29x0.27x0.29x0.31x0.38x
Equity ratio72.4%66.6%66.6%65.6%64.2%61.3%
Interest coverage21.94x11.30x13.37x12.03x21.10x4.73x
R&D as a share of sales1.0%1.3%1.4%1.4%1.2%0.3%
Buybacks as a share of market value0.3%1.1%0.8%-0.0%0.5%1.4%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.7%11.3%10.2%
Operating income35.0%21.7%15.1%
Net income39.4%40.8%22.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin54.7%53.2%52.7%51.6%
Operating margin18.2%16.3%16.0%14.0%
Net margin14.2%12.4%11.5%9.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings8.39.610.110.414.712.79.315.413.927.9
Price to sales1.31.21.30.81.80.60.60.61.01.7

Dividends and splits

Per share, in the currency the company pays

Paid for 10 years. Last went ex-dividend on 3 Jun 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.150.1990.170.1040.0810.120.0220.045

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.